Literature DB >> 19707930

Helicobacter pylori and microcirculation.

Hidekazu Suzuki1, Masayuki Suzuki, Hiroyuki Imaeda, Toshifumi Hibi.   

Abstract

Microcirculation is one of the susceptible targets in the pathogenesis of disorders caused by exogenous pathogens, such as the well-known bacterium, Helicobacter pylori (Hp). While extensive studies have been published on the kinetics of Hp infection, only a few have dealt with the microcirculatory aspects of Hp-induced disorders. This review summarizes the recent developments in the elucidation of the pathophysiology of disorders caused by Hp infection, focusing on the microcirculatory aspect. Animal and human studies were systematically reviewed to identify published data on the microcirculatory aspects of Hp infection. This updated summary of the microcirculatory aspects of Hp-induced disorders illustrates potential approaches that might be used to clarify the pathophysiology of the gastric and extragastric sequelae of Hp infection and the therapeutic strategies that could be adopted.

Entities:  

Mesh:

Year:  2009        PMID: 19707930     DOI: 10.1080/10739680902949953

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  3 in total

1.  Post-infectious Functional Dyspepsia - A Novel Disease Entity among Functional Gastrointestinal Disorders - Relation to Helicobacter pylori Infection? (Neurogastroenterol Motil 2009;21:832-e56).

Authors:  Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 2.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

3.  Oxidative DNA damage as a potential early biomarker of Helicobacter pylori associated carcinogenesis.

Authors:  Yasir Raza; Adnan Khan; Amber Farooqui; Muhammad Mubarak; Alex Facista; Syed Shakeel Akhtar; Saeed Khan; Javed Iqbal Kazi; Carol Bernstein; Shahana Urooj Kazmi
Journal:  Pathol Oncol Res       Date:  2014-03-25       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.